Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-08-07CAI144GEORGE H POSTE plan to sell securities of CARIS LIFE SCIENCES, INC. under Form 144MEDIUM
GEORGE H POSTE filed Form 144 to notify SEC of plan to sell 30000 units of CARIS LIFE SCIENCES, INC. securities around 2026-08-07, with aggregate market value of $642,633.00. The total outstanding units is 282595186.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in pas...
Mid CapBiotechnology
2026-08-07CRBP144Stifel, Nicolaus & Company, Inc CIAS /FA plan to sell securities of Corbus Pharmaceuticals Holdings, Inc. under Form 144MEDIUM
Stifel, Nicolaus & Company, Inc CIAS /FA filed Form 144 to notify SEC of plan to sell 17000 units of Corbus Pharmaceuticals Holdings, Inc. securities around 2026-08-07, with aggregate market value of $171,396.00. The total outstanding units is 19341293.0. The amount planned to be sold represents 0.09% of total outstand...
Micro CapBiotechnology
2026-08-07CRBP144Stifel, Nicolaus & Company, Inc CIAS /FA plan to sell securities of Corbus Pharmaceuticals Holdings, Inc. under Form 144MEDIUM
Stifel, Nicolaus & Company, Inc CIAS /FA filed Form 144 to notify SEC of plan to sell 12000 units of Corbus Pharmaceuticals Holdings, Inc. securities around 2026-08-07, with aggregate market value of $120,971.00. The total outstanding units is 19341293.0. The amount planned to be sold represents 0.06% of total outstand...
Micro CapBiotechnology
2026-08-07DNTH144MARINO GARCIA plan to sell securities of DIANTHUS THERAPEUTICS OPCO, INC. under Form 144MEDIUM
MARINO GARCIA filed Form 144 to notify SEC of plan to sell 126000 units of DIANTHUS THERAPEUTICS OPCO, INC. securities around 2026-08-07, with aggregate market value of $13,619,340.00. The total outstanding units is 55934378.0. The amount planned to be sold represents 0.23% of total outstanding units; ...
Mid CapBiotechnology
2026-08-07DNTH144ADAM VENESS plan to sell securities of Dianthus Therapeutics, Inc. under Form 144MEDIUM
ADAM VENESS filed Form 144 to notify SEC of plan to sell 3833 units of Dianthus Therapeutics, Inc. securities around 2026-08-07, with aggregate market value of $421,323.36. The total outstanding units is 55934378.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3...
Mid CapBiotechnology
2026-08-07DNTH144MARINO GARCIA plan to sell securities of Dianthus Therapeutics, Inc. under Form 144MEDIUM
MARINO GARCIA filed Form 144 to notify SEC of plan to sell 40000 units of Dianthus Therapeutics, Inc. securities around 2026-08-07, with aggregate market value of $4,396,800.00. The total outstanding units is 55934378.0. The amount planned to be sold represents 0.07% of total outstanding units; ...
Mid CapBiotechnology